38955-11-2 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
3-Methylisoxazole-5-carboxamide is used as a reagent in pharmaceutical research and drug development due to its diverse range of activities, including antimicrobial, antifungal, and antitumor properties. Its potential applications in medicinal chemistry and organic synthesis make it a promising candidate for the development of new drugs and therapeutic agents.
Used in Medicinal Chemistry:
3-Methylisoxazole-5-carboxamide is used as a building block in the synthesis of various pharmaceutical compounds. Its unique structure allows for the creation of novel molecules with potential therapeutic applications.
Used in Organic Synthesis:
3-Methylisoxazole-5-carboxamide is used as a versatile intermediate in organic synthesis, enabling the production of a wide range of chemical compounds with different functionalities.
Used in Antimicrobial Applications:
3-Methylisoxazole-5-carboxamide is used as an antimicrobial agent, exhibiting activity against various types of bacteria. Its ability to inhibit bacterial growth makes it a valuable component in the development of new antimicrobial drugs.
Used in Antifungal Applications:
3-Methylisoxazole-5-carboxamide is used as an antifungal agent, showing potential in treating fungal infections. Its antifungal properties contribute to the development of new antifungal medications.
Used in Antitumor Applications:
3-Methylisoxazole-5-carboxamide is used as an antitumor agent, demonstrating potential in inhibiting the growth of cancer cells. Its antitumor properties make it a promising candidate for the development of new cancer therapies.
Used in Anti-inflammatory and Analgesic Applications:
3-Methylisoxazole-5-carboxamide is used as an anti-inflammatory and analgesic compound, highlighting its significance in the pharmaceutical industry. Its potential to reduce inflammation and alleviate pain makes it a valuable asset in the development of new medications for these purposes.
Check Digit Verification of cas no
The CAS Registry Mumber 38955-11-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,8,9,5 and 5 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 38955-11:
(7*3)+(6*8)+(5*9)+(4*5)+(3*5)+(2*1)+(1*1)=152
152 % 10 = 2
So 38955-11-2 is a valid CAS Registry Number.
38955-11-2Relevant academic research and scientific papers
THIADIAZOLEDIOXIDES AND THIADIAZOLEOXIDES AS CXC- AND CC-CHEMOKINE RECEPTOR LIGANDS
-
Page 279, (2008/06/13)
Disclosed are novel compounds of the formula (IA) and the pharmaceutically acceptable salts and solvates thereof. Examples of groups comprising Substituent A include heteroaryl, aryl, heterocycloalkyl, cycloalkyl, aryl, alkynyl, alkenyl, aminoalkyl, alkyl or amino. Examples of groups comprising Substituent B include aryl and heteroaryl. Also disclosed is a method of treating a chemokine mediated diseases, such as, cancer, angiogenisis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and cardiac reperfusion injury, acute pain, acute and chronic inflammatory pain, and neuropathic pain using a compound of formula (IA).
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
-
Page 151, (2008/06/13)
There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
-
Page 152, (2008/06/13)
There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.
Hypoglycemic 5-substituted oxazolidine-2,4-diones
-
, (2008/06/13)
Hypoglycemic 5-chromanyl, 2,3-dihydro-5-benzo[b]furanyl, 5-pyridyl, 5-quinolyl, 5-pyrrolyl, 5-indolyl, 5-thiazolyl, 5-oxazolyl, 5-isothiazolyl and 5-isoxazolyl oxazolidine-2,4-diones and the pharmaceutically acceptable salts thereof; certain 3-acylated derivatives thereof; a method of treating hyperglycemic animals therewith; and intermediates useful in the preparation of said compounds.
